These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 8671820

  • 1. Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients?
    Braun J, Hammerschmidt M, Schreiber M, Heidler R, Hörl WH.
    Nephrol Dial Transplant; 1996 Mar; 11(3):492-7. PubMed ID: 8671820
    [Abstract] [Full Text] [Related]

  • 2. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M, Salopek S, Möller M, Schliesser J, Klooker P, Reddig J, Gansert U, Brass H.
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [Abstract] [Full Text] [Related]

  • 3. [Red cell zinc protoporphyrin and its ratio to serum ferritin (ZPP/logSF index) in the detection of iron deficiency in patients with end-stage renal failure on hemodialysis].
    Matuszkiewicz-Rowińska J, Ostrowski G, Niemczyk S, Przedlacki J, Wardyn K, Puka J, Włodarczyk D, Switalski M, Zakrzewska T, Ostrowski K.
    Pol Arch Med Wewn; 2003 Jul; 110(1):703-10. PubMed ID: 14682204
    [Abstract] [Full Text] [Related]

  • 4. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
    Baldus M, Walter H, Thies K, Anders C, Stein M, Hellstern P, Brass H.
    Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
    [Abstract] [Full Text] [Related]

  • 5. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC.
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [Abstract] [Full Text] [Related]

  • 6. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J, Lindner K, Schreiber M, Heidler RA, Hörl WH.
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [Abstract] [Full Text] [Related]

  • 7. Erythrocyte zinc protoporphyrin.
    Braun J.
    Kidney Int Suppl; 1999 Mar; 69():S57-60. PubMed ID: 10084287
    [Abstract] [Full Text] [Related]

  • 8. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients.
    Fishbane S, Lynn RI.
    Am J Kidney Dis; 1995 Mar; 25(3):426-32. PubMed ID: 7872320
    [Abstract] [Full Text] [Related]

  • 9. Central role of zinc protoporphyrin in staging iron deficiency.
    Hastka J, Lasserre JJ, Schwarzbeck A, Hehlmann R.
    Clin Chem; 1994 May; 40(5):768-73. PubMed ID: 8174250
    [Abstract] [Full Text] [Related]

  • 10. Zinc protoporphyrin/heme ratio for diagnosis of preanemic iron deficiency.
    Rettmer RL, Carlson TH, Origenes ML, Jack RM, Labb RF.
    Pediatrics; 1999 Sep; 104(3):e37. PubMed ID: 10469820
    [Abstract] [Full Text] [Related]

  • 11. Soluble transferrin receptor and zinc protoporphyrin--competitors or efficient partners?
    Metzgeroth G, Adelberger V, Dorn-Beineke A, Kuhn C, Schatz M, Maywald O, Bertsch T, Wisser H, Hehlmann R, Hastka J.
    Eur J Haematol; 2005 Oct; 75(4):309-17. PubMed ID: 16146537
    [Abstract] [Full Text] [Related]

  • 12. [Zinc protoporphyrin (ZPP) in diagnosis of anemia].
    Paszkowska M, Jezyńska A, Król M, Rokicka-Piotrowicz M, Kuratowska Z.
    Pol Arch Med Wewn; 1997 Dec; 98(12):520-6. PubMed ID: 9640080
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of zinc protoporphyrin to detect iron deficiency in Kenyan pregnant women.
    Mwangi MN, Maskey S, Andang o PE, Shinali NK, Roth JM, Trijsburg L, Mwangi AM, Zuilhof H, van Lagen B, Savelkoul HF, Demir AY, Verhoef H.
    BMC Med; 2014 Nov 26; 12():229. PubMed ID: 25428714
    [Abstract] [Full Text] [Related]

  • 14. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 15. Regular low-dose intravenous iron therapy improves response to erythropoietin in haemodialysis patients.
    Taylor JE, Peat N, Porter C, Morgan AG.
    Nephrol Dial Transplant; 1996 Jun 03; 11(6):1079-83. PubMed ID: 8671972
    [Abstract] [Full Text] [Related]

  • 16. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C, Grill A, Decostanzi E, Maddalena E, Barbieri S, Martina G, Fop F, Buglione E, Grechi D, David O, Saitta M, Piccoli G.
    Clin Nephrol; 2000 Jan 03; 53(1):42-7. PubMed ID: 10661481
    [Abstract] [Full Text] [Related]

  • 17. The role of zinc protoporphyrin measurement in the differentiation between primary myelofibrosis and essential thrombocythaemia.
    Metzgeroth G, Kanders EM, Erben P, Hofmann WK, Hastka J.
    Ann Hematol; 2011 Apr 03; 90(4):389-94. PubMed ID: 20922526
    [Abstract] [Full Text] [Related]

  • 18. Zinc protoporphyrin, a useful parameter to address hyperferritinemia.
    Metzgeroth G, Schultheis B, Dorn-Beineke A, Hehlmann R, Hastka J.
    Ann Hematol; 2007 May 03; 86(5):363-8. PubMed ID: 17333188
    [Abstract] [Full Text] [Related]

  • 19. Zinc protoporphyrin and iron-deficient erythropoiesis.
    Garrett S, Worwood M.
    Acta Haematol; 1994 May 03; 91(1):21-5. PubMed ID: 8171931
    [Abstract] [Full Text] [Related]

  • 20. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin.
    Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, Gammaro L, Brocco G, Restivo G, Bernich P, Lupo A, Maschio G.
    Nephrol Dial Transplant; 2001 Jul 03; 16(7):1416-23. PubMed ID: 11427634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.